|
業務類別
|
Biotechnology |
|
業務概覽
|
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions. |
| 公司地址
| 2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608 |
| 電話號碼
| +1 510 204-7200 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.xoma.com |
| 員工數量
| 14 |
| Mr. Jeffrey Trigilio |
Chief Financial Officer |
-- |
15/01/2026 |
| Mr. Bradley Sitko |
Chief Investment Officer |
美元 563.04K |
30/03/2026 |
| Ms. Maricel Perea Montano |
Chief Legal Officer and Corporate Secretary |
-- |
30/03/2026 |
| Mr. Owen P. Hughes, Jr |
Chief Executive Officer and Director |
美元 707.94K |
30/03/2026 |
|
|
| Mr. Jack L. Wyszomierski, M.S. |
Chairman of the Board |
30/03/2026 |
| Ms. Heather L. Franklin |
Independent Director |
30/03/2026 |
| Mr. Joseph M. Limber |
Independent Director |
30/03/2026 |
| Mr. Matthew D. Perry |
Independent Director |
30/03/2026 |
| Ms. Barbara Kosacz, J.D. |
Independent Director |
30/03/2026 |
| Ms. Natasha A. Hernday |
Independent Director |
30/03/2026 |
| Mr. Owen P. Hughes, Jr |
Chief Executive Officer and Director |
30/03/2026 |
|
|
|
|
